Roche’s Etrolizumab Failure ‘Removes Big Pipeline Opportunity’

Topline Phase III Data Showed Mixed Induction Results, Maintenance Miss

 
• By Sten Stovall
  
Ulcerative_Colitis
Etrolizumab represents Roche's first attempt at ulcerative colitis and Crohn’s disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Clinical Trials

More from R&D